FR 
Select a Company
0.05 GHS 0 / 0%
As of 14-Jan-2025
Intravenous Infusions Limited
Health Care Pharmaceuticals & Biotechnology0.05 GHS 0 / 0%
As of 14-Jan-2025
Prev. Close
0.05
Volume
0
Turnover
GHS 0.00
Deals
--
Shares Outstanding
258.82 mln
Market Cap.
GHS 12.94 mln
Loading Chart ...
52W RANGE
0.05 - 0.05
1W
--
1M
--
3M
--
YTD
--
1Y
--
Profile
Announcements
News
Reports
Dividends
About the company
Intravenous Infusions Limited was incorporated in 1969 and began operations in 1974 as the first pharmaceutical company producing intravenous fluids in Ghana. The main business activity of IIL is the production of intravenous infusions for therapeutic purposes.
Website
www.iil.com.gh
info@iil.com.gh
Website
www.iil.com.gh
info@iil.com.gh
| SYMBOL IIL |
ISIN GH0000001258 |
| Founded 1974 |
Listed 2015 |
| Phone (+233) 342 202 04/20141/20440 |
FAX (+233) 342 20125 |
Plot 4/7 Blk L, Effiduase-Koforidua, P.O Box KF 63, Koforidua -Ghana |
|
Competitors
| Dannex Ayrton Starwin Plc | 0.38 | -- |
| IIL | Notice of annual general meeting | 7 Jun. 2024 |
| IIL | Appointments | 25 Sep. 2020 |
| IIL | AGM | 23 Jun. 2020 |
| IIL | Director Appointment | 9 May. 2018 |
| IIL | Notice of AGM | 18 May. 2017 |
| IIL | Notice of AGM | 13 May. 2016 |
| IIL | Results of IPO | 14 Dec. 2015 |
| IIL - IPO Prospectus - 2015 | 13 Jul. 2015 |
Research & Analysis
Annual & Financials Reports
| Annual Report | 2023 |
| Annual Report | 2022 |
| Annual Report | 2021 |
| Annual Report | 2019 |
| Annual Report | 2018 |
| Annual Report | 2017 |
| Annual Report | 2016 |
| Annual Report | 2015 |
| Financial Statements | 2015 |
| IPO Prospectus | 2015 |
Â
| 0.0044 GHS | Final | 17 Aug. 2020 |
| 0.00384 GHS | Final | 21 Jun. 2019 |
